Form 4: Cigna Group CEO David Cordani Reports Acquisition of Shares and Stock Options
SEC Form 4
Cigna Group's CEO, David Cordani, reported acquiring shares and stock options, including restricted shares and those through the company's 401(k) plan.
Summary
- David Cordani, CEO of Cigna Group, filed a Form 4 detailing changes in beneficial ownership.
- On February 28, 2024, Cordani acquired 9,927 shares of common stock at $0.00, which are restricted and vest in three equal annual installments starting March 1, 2025.
- He also acquired 1,727.2938 shares through Cigna Group's 401(k) plan.
- Cordani was granted an option to buy 36,162 shares of common stock at an exercise price of $336.475, vesting in three equal annual installments beginning March 1, 2025, and expiring on February 28, 2034.
- Following these transactions, Cordani directly owns 346,710 shares of common stock.
- He also indirectly owns 99,918 shares through a GRAT and 153,801 shares through a trust.
- Additionally, he indirectly owns 1,727.2938 shares through the 401(k) plan.
- Cordani directly owns options for 36,162 shares.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a standard regulatory filing detailing transactions. The acquisition of shares and options by the CEO could be seen as a slightly positive signal, but it's not overtly bullish.
Positives
- The CEO's acquisition of shares and stock options could be interpreted as a positive signal, indicating confidence in the company's future performance.
Future Outlook
The document does not contain explicit forward-looking statements, but the vesting schedules for the restricted shares and stock options extend into the future.
Industry Context
Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders. These filings are closely watched by investors to gauge management's sentiment and confidence in the company.
Stakeholder Impact
- The transactions reported may influence investor perception of Cigna Group's stock.
Key Dates
| Date | Description |
|---|---|
| 02/28/2024 | Date of transaction for common stock and employee stock option acquisition. |
| 03/01/2024 | Date of signature for the report. |
| 03/01/2025 | First vesting date for restricted shares and stock options. |
| 02/28/2034 | Expiration date for the employee stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.